Certara Inc (CERT)vsTempus AI, Inc. Class A Common Stock (TEM)
CERT
Certara Inc
$7.55
+1.75%
HEALTHCARE · Cap: $1.18B
TEM
Tempus AI, Inc. Class A Common Stock
$59.01
+0.46%
HEALTHCARE · Cap: $11.66B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 240% more annual revenue ($1.43B vs $421.75M). CERT leads profitability with a -16.2% profit margin vs -17.8%. CERT earns a higher WallStSmart Score of 31/100 (F).
CERT
Avoid31
out of 100
Grade: F
TEM
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+54.4%
Fair Value
$15.21
Current Price
$7.55
$7.66 discount
Intrinsic value data unavailable for TEM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 21.6% year-over-year
Areas to Watch
1.0% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -1.5% — below average capital efficiency
0.0% earnings growth
Trading at 23.9x book value
ROE of -57.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : CERT
The strongest argument for CERT centers on Price/Book.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.
Bear Case : CERT
The primary concerns for CERT are Revenue Growth, Altman Z-Score, Market Cap.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.
Key Dynamics to Monitor
CERT profiles as a turnaround stock while TEM is a growth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.72 — expect wider price swings.
TEM is growing revenue faster at 21.6% — sustainability is the question.
CERT generates stronger free cash flow (9M), providing more financial flexibility.
Bottom Line
CERT scores higher overall (31/100 vs 28/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Certara Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?